Patents Assigned to The University of British Columbia
  • Publication number: 20210345601
    Abstract: Provided herein are perfusion fluids for enzymatically cleaving A-antigens from a donor organ, and methods, uses, associated therewith. In particular, the perfusion fluids comprise two enzymes, GalNAcDeacetylase and Galactosaminidase and the fluids may further comprise a buffered extracellular solution and/or a crowing agent. Furthermore, the compositions described herein were found to have activity at temperatures and pH levels suitable for cell viability.
    Type: Application
    Filed: August 16, 2019
    Publication date: November 11, 2021
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA, UNIVERSITY HEALTH NETWORK
    Inventors: Marcelo CYPEL, Aizhou WANG, Shafique KESHAVJEE, Stephen G. WITHERS, Peter RAHFELD, Jayachandran KIZHAKKEDATHU
  • Patent number: 11168100
    Abstract: A Brønsted-Lowry acid initiator system for cationic polymerization of an ethylenically unsaturated monomer involves an initiator having a structure of Formula (I) in an anhydrous polymerization medium: where: M is tantalum (Ta), vanadium (V) or niobium (Nb); R1, R2, R3 and R4 are the same or different and are independently H, F, Cl, Br, I, alkyl or aryl, or two or more of R2, R3, R4 and R5 on a same benzene ring are taken together to form a bicyclic, tricyclic or tetracyclic moiety with the benzene ring, with the proviso that all of R1, R2, R3 and R4 on the same benzene ring are not H; L is absent or a molecule that coordinates to H+; and, x is 0 when L is absent, or x is 0.5 or more when L is present.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 9, 2021
    Assignees: ARLANXEO SINGAPORE PTE. LTD., THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Gilles Arsenault, Hazin Khatera, Derek Gates
  • Patent number: 11167034
    Abstract: This invention provides compositions for controlled localized release of one or more drugs within a subject. More particularly, described herein are compositions comprising a hydrophobic water-insoluble polymer, a low molecular weight biocompatible glycol, and one or more drugs. The compositions described herein may also optionally include a di-block copolymer and/or a swelling agent.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: November 9, 2021
    Assignee: The University of British Columbia
    Inventors: John K. Jackson, Martin E. Gleave, Veronika Schmitt, Claudia Kesch
  • Patent number: 11159090
    Abstract: Synchronous rectification methods and algorithms, and polarity sensing techniques, based on the homopolarity cycle concept for conduction loss reduction in LLC resonant converters are provided. In a half bridge rectifier configuration, one of rectifier switches is switched ON when the polarity of the inverter and rectifier voltages are both positive and the other rectifier switch is switched ON when both polarities are negative.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: October 26, 2021
    Assignees: ALPHA TECHNOLOGIES LTD., The University of British Columbia
    Inventors: Mehdi Mohammadi, Martin Ordonez, Mohammad Mahdavi, Peter Ksiazek, Navid Shafiei, Rahul Khandekar
  • Patent number: 11154836
    Abstract: A reactor that operates with ultraviolet light emitting diodes (UV-LEDs) to attain UV photoreactions or UV photo-initiated reaction in a fluid flow for various applications, including water purification. The UV-LED reactor is comprised of a conduit means for passing fluid flow, an ultraviolet light emitting diode (UV-LED), and a radiation-focusing element to focus the UV-LED radiation to the fluid in the longitudinal direction of the conduit proportionally to the fluid velocity in the cross section of the conduit.
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: October 26, 2021
    Assignee: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventor: Fariborz Taghipour
  • Publication number: 20210325429
    Abstract: A method for the patterning and control of single electrons on a surface is provided that includes implementing scanning tunneling microscopy hydrogen lithography with a scanning probe microscope to form charge structures with one or more confined charges; performing a series of field-free atomic force microscopy measurements on the charge structures with different tip heights, where interaction between the tip and the confined charge are elucidated; and adjusting tip heights to controllably position charges within the structures to write a given charge state. The present disclose also provides a Gibb's distribution machine formed with the method for the patterning and control of single electrons on a surface. A multi bit true random number generator and neural network learning hardware formed with the above described method are also provided.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Applicants: Quantum Silicon Inc., National Research Council of Canada, The University of British Columbia
    Inventors: Robert Wolkow, Mohammad Rashidi, Wyatt Vine, Thomas Dienel, Lucian Livadaru, Taleana Huff, Jacob Retallick, Konrad Walus, Jason Pitters, Roshan Achal
  • Publication number: 20210324361
    Abstract: Provided herein are enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatuses and systems associated therewith. In particular, the composition comprises two enzymes, GalNAcDeacetylase and Galactosaminidase and the composition may further comprise a crowding agent. Furthermore, the compositions described herein were found to have activity a temperatures and pH levels suitable for cell viability.
    Type: Application
    Filed: August 16, 2019
    Publication date: October 21, 2021
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Stephen G. WITHERS, Peter RAHFELD, Jayachandran KIZHAKKEDATHU
  • Publication number: 20210317497
    Abstract: Provided are transgenic organisms, such as plants and plant parts, cells, and related compositions and methods for producing and monitoring the genotype for enhanced production of montbretin A and/or its precursors. For example, provided is a transgenic organism comprising at least one heterologous nucleic acid operatively linked to a promoter, wherein the heterologous nucleic acid encodes at least one enzyme in a montbretin A (MbA) metabolic pathway. The organisms can be a plant, plant part, or plant cell, or a microorganism such as a yeast. Also provided is a method for producing at least one montbretin A (MbA) precursor and/or MbA, comprising permitting the expression of the at least one heterologous nucleic acid in the transgenic organism. The disclosure also provides isolated nucleic acid molecules that comprise sequence encoding at least one enzyme in a montbretin A (MbA) metabolic pathway and vectors comprising the nucleic acids.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 14, 2021
    Applicant: The University of British Columbia
    Inventors: Carl Joerg BOHLMANN, Sandra IRMISCH, Seohyun JO
  • Patent number: 11142508
    Abstract: Compounds having a structure of Formula I or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, and X, are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: October 12, 2021
    Assignees: The University of British Columbia, Provincial Health Services Authority
    Inventors: Raymond J. Andersen, Marianne Dorothy Sadar, Kunzhong Jian, Nasrin R. Mawji, Jun Wang, Carmen Adriana Banuelos, Yu-Chi Yang
  • Patent number: 11142561
    Abstract: Provided are methods, uses and pharmaceutical compositions for treatment of cancer with a B1SP fusion protein in a biologically effective amount sufficient to cause cell death of a prostate cancer cell or to inhibit proliferation of the prostate cancer cells. The cancer may be prostate cancer, breast cancer, ovarian cancer, bladder cancer, kidney cancer, glioblastoma or endometrial cancer. The prostate cancer may be an androgen receptor (AR) positive prostate cancer and the B1SP fusion protein may include a sema domain, a structural stabilization domain; and a half life extending moiety.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: October 12, 2021
    Assignee: The University of British Columbia
    Inventors: Christopher J. Ong, James William Peacock, Martin E. Gleave
  • Patent number: 11129591
    Abstract: A computer-implemented system for facilitating echocardiographic image analysis is disclosed. The system includes at least one processor configured to receive signals representing a first at least one echocardiographic image, associate the image with a first view category of a plurality of predetermined view categories, determine, based on the first at least one echocardiographic image and the first view category, a first quality assessment value representing a view category specific quality assessment of the first at least one echocardiographic image, and produce signals representing the first quality assessment value for causing the first quality assessment value to be associated with the first at least one echocardiographic image. The at least one processor may also be configured to do the above steps for a second at least one echocardiographic and a second view category that is different from the first view category image. Other systems, methods, and computer-readable media are also disclosed.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: September 28, 2021
    Assignee: The University of British Columbia
    Inventors: Purang Abolmaesumi, Robert Rohling, Amir H. Abdi, Teresa S. M. Tsang
  • Patent number: 11131650
    Abstract: A method of facilitating ultrasonic analysis of a subject is provided. The method involves producing signals for causing a set of outgoing ultrasonic signals to be transmitted to the subject, wherein the set of outgoing ultrasonic signals is defined at least in part by a variable imaging parameter that varies over time in accordance with a variable imaging parameter function, the variable imaging parameter function represented or representable at least in part by a function characteristic, receiving signals representing a time dependent representation of the subject generated from a set of received ultrasonic signals scattered by the subject, determining at least one property representation of the subject based on the function characteristic and the time dependent representation of the subject, and producing signals representing the at least one property representation of the subject to facilitate analysis of the subject. Systems, non-transitory computer readable media, and other methods are also provided.
    Type: Grant
    Filed: March 18, 2021
    Date of Patent: September 28, 2021
    Assignees: The University of British Columbia, Queen's University at Kingston
    Inventors: Purang Abolmaesumi, Parvin Mousavi
  • Patent number: 11125748
    Abstract: According to one embodiment of the present invention, a structure includes: a substrate having a patterned surface of one or more binding sites; and a molecular shape made by a polynucleotide platform having a shape corresponding to a shape of a binding site of the one or more binding sites, the molecular shape being bound to one of the one or more binding sites.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: September 21, 2021
    Assignees: UNIVERSITY OF BRITISH COLUMBIA, CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Ashwin Gopinath, Christopher Thachuk, David G. Kirkpatrick, Paul W. Rothemund
  • Patent number: 11116897
    Abstract: The invention relates to administration of clinical anesthesia. Particular embodiments provide systems and methods for controlled delivery of a combination of an analgesic agent and a hypnotic agent. More specifically, the invention relates to closed-loop control systems/methods for automatically controlling the administration of a combination of a hypnotic agent and an analgesic agent in a clinical anesthesia setting which incorporate feedback based on one or more indirect measures/indicia of analgesia. The invention further relates to such control systems/methods that account for limitations of such indirect measures/indicia of analgesia.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: September 14, 2021
    Assignee: The University of British Columbia
    Inventors: Guy Dumont, Klaske Van Heusden, Mark Ansermino
  • Patent number: 11100888
    Abstract: A method of producing at least one output image signal representing, at least, a plurality of output luminance values in an output range of luminance values is disclosed. The method involves: identifying a mapping function based at least in part on a perceptually scaled distribution of a plurality of input luminance values in an input range of luminance values different from the output range of luminance values; transforming the plurality of input luminance values into respective perceptually scaled output luminance values according to the mapping function; transforming the perceptually scaled output luminance values into respective ones of the plurality of output luminance values; and producing the at least one output signal representing, at least, the plurality of output luminance values. Computer-readable media and apparatuses are also disclosed.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: August 24, 2021
    Assignee: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Panos Nasiopoulos, Stylianos Ploumis, Mahsa Talebpourazad, Ronan Boitard, Pedram Mohammadi
  • Publication number: 20210239683
    Abstract: Provided herein are compositions comprising: a scaffold polymer having one or more acryloyl groups or one or more methacryloyl groups; optionally a porogen and a crosslinking agent, compositions that upon crosslinking form a hydrogel for use in cell encapsulation and methods for immunocytochemistry of encapsulated cells. Scaffold polymers used are selected from: Poly(ethylene glycol) diacrylate (PEGDA); Poly(ethylene glycol) dimethylacrylate (PEGDMA); Poly(ethylene glycol) methyl ether acrylate (PEGMEA); Poly(ethylene glycol) methacrylate (PEGMA); and Poly(ethylene glycol) methyl ether methacrylate (PEGMEMA), and porogens selected from: Poly(ethylene glycol) (PEG); Chitosan; Agarose; Dextran; Hyaluronic acid; Poly(methyl methacrylate) (PMMA); Cellulose and derivatives thereof; Gelatin and derivatives thereof; and Acrylamide and derivatives thereof. The invention also provides, at least in part, compositions for forming a porous hydrogel around a cell suitable for immunostaining of cells within the hydrogel.
    Type: Application
    Filed: May 3, 2019
    Publication date: August 5, 2021
    Applicant: The University of British Columbia
    Inventors: Hongshen Ma, Jeong-Hyun Lee
  • Patent number: 11072772
    Abstract: Microfluidic devices and methods for perfusing a cell with perfusion fluid are provided herein, wherein the gravitational forces acting on the cell to keep the cell at or near a retainer or a retaining position exceed the hydrodynamic forces acting on the cell to move it toward an outlet. Also provided, are methods for assaying cell products within the microfluidic device.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: July 27, 2021
    Assignee: The University of British Columbia
    Inventors: Carl L. G. Hansen, Veronique Lecault, James M. Piret, Anupam Singhal
  • Publication number: 20210220027
    Abstract: Systems and methods for intermedullary bone fracture fixation are described herein. The fixation device includes a main body having a flexible state and a rigid state. The fixation device further includes a proximal interface coupled to a proximal end of the main body to anchor the fixation device to an exterior surface of the bone and a distal interface coupled to a distal end of the main body to anchor the fixation device to an interior cavity of the bone. The fixation device further includes a locking interface to configured to convert the main body from the flexible state to the rigid state.
    Type: Application
    Filed: April 8, 2021
    Publication date: July 22, 2021
    Applicants: The University of British Columbia, British Columbia Cancer Agency Branch
    Inventors: Edward Scott HARSHMAN, Steven Charles DIMMER, David Thomas STINSON
  • Patent number: 11059795
    Abstract: The present invention relates to compounds of formula (I)-(VI) and/or (A)-(H-I), or any subgenera thereof, or a pharmaceutically acceptable salt, tautomer or stereoisomer. The compounds of the present disclosure are useful in modulating androgen receptor activity and for treating cancer including prostate cancer.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: July 13, 2021
    Assignees: ESSA Pharma, Inc., The University of British Columbia, Provincial Health Services Authority
    Inventors: Han-Jie Zhou, Peter Virsik, Raymond John Andersen, Marianne Dorothy Sadar
  • Publication number: 20210180153
    Abstract: A method for refining lithium from a crude brine includes charging a crude brine into a feeder tank held at a temperature T1 and containing a sufficient carbonate source to precipitate all carbonate-forming solids in the crude brine to form a precipitate mixture and a crystal free supernatant; pumping the crystal free supernatant from the feeder tank to a first crystallization reactor that is held at a temperature T2 to crystallize a lithium carbonate salt out of the crystal free supernatant; wherein the temperature T1 is lower than the temperature T2; and controlling a flow rate to maintain a steady state concentration of the lithium carbonate salt in the solution phase of the crystallization reactor.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 17, 2021
    Applicant: The University of British Columbia
    Inventors: Jason Ellis HEIN, Johannes Pierre KENNEPOHL